Sunrise Bio Technology Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 08-07-2024
- Paid Up Capital ₹ 2.22 M
as on 08-07-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -9.38%
(FY 2020)
- Profit 13.82%
(FY 2020)
- Ebitda 20.77%
(FY 2020)
- Net Worth 3.48%
(FY 2020)
- Total Assets -0.61%
(FY 2020)
About Sunrise Bio Technology
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 2.22 M, as per Ministry of Corporate Affairs (MCA) records.
Agam Gupta and Sanjay Gupta serve as directors at the Company.
- CIN/LLPIN
U73100DL2005PTC132798
- Company No.
132798
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sunrise Bio Technology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Agam Gupta  | Director | 19-Apr-2021 | Current |
| Sanjay Gupta | Director | 10-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Sunrise Bio Technology.
Sunrise Bio Technology Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 9.38% decrease. The company also saw a substantial improvement in profitability, with a 13.82% increase in profit. The company's net worth moved up by a moderate rise of 3.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunrise Bio Technology?
In 2019, Sunrise Bio Technology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P R B Hardcast Steel And Ingots Private LimitedActive 19 years 5 monthsAgam Gupta and Sanjay Gupta are mutual person
- Manish Buildestate Private LimitedActive 16 years 5 months
Agam Gupta and Sanjay Gupta are mutual person
- Metro Buildvision Private LimitedActive 17 years 7 months
Agam Gupta and Sanjay Gupta are mutual person
- Devon Chemicals Private LimitedActive 14 years 5 months
Agam Gupta and Sanjay Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunrise Bio Technology?
Unlock and access historical data on people associated with Sunrise Bio Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunrise Bio Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunrise Bio Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
